Anesthésie, analgésie, réanimation
-
Anesth Analg (Paris) · Jan 1981
[Regional intravenous guanethidine for sympathetic block in algodystrophic syndromes (author's transl)].
The authors report their experience with 35 guanethidine intravenous local injections in algodystrophic and neurotrophic syndromes. Although excellent results are obtained in post-traumatic algodystrophies which are treated early, they are less remarkable in long standing sequelae due to injuries of the nervous system, and where, at best, only an antalgic effect can be expected.
-
Anesth Analg (Paris) · Jan 1981
[Hundred cases of general anesthesia for laryngoscopy and/or bronchoscopy, in children under five years age (author's transl)].
The authors describe an anesthetic technique used for endoscopies (laryngo-tracheo-bronchoscopies) in 100 children under five years age. Three different apparatus for jet ventilation are used: manual injection, automatic injection and high frequency positive pressure ventilation. ⋯ With the second one (Wolf injectomat), injection of O2 or O2/N2O is automatic. The aga bronchovent is used for high frequency positive ventilation with O2.
-
Epidural opiate application was performed in 75 patients with chronic pain due to abdominal cancer. To reduce the risk of local infection, the epidural catheter was in part placed subcutaneously. Degree and duration of analgesia were determined after epidural morphine (with and without bupivacaine), pethidine or fentanyl. ⋯ A combination of epidural morphine with small doses of local anesthetics caused prolonged action and delayed the onset of tolerance. Besides slight influences on respiratory function, which may be referred to the initial period of systemic absorption, there were no relevant side-effects. Regarding certain precautions the epidural application of morphine may have advantages in comparison to systemic analgetics in treatment of chronic pain.
-
Anesth Analg (Paris) · Jan 1981
[Curing trial of complicated oncologic pain by D-phenylalanine (author's transl)].
Aim of investigations: Very often, chronic pain treatments used for the management of terminal ill cancer patients do not prevent acute or incident pain from coming up. For twenty months D-phenylalanine (DPA), an enkephalinase inhibitor, has been investigated in order to forestall this pain. ⋯ DPA seems a useful drug to prevent acute or incident pain in malignant diseases. Our data point out the consequences the enkephalinases inhibitors will take up for the cure of intractable cancer pain.